GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Wiley  (2)
  • Feng, Bo  (2)
Material
Publisher
  • Wiley  (2)
Language
Years
  • 1
    In: Diabetes/Metabolism Research and Reviews, Wiley
    Abstract: To assess the prevalence of diabetic peripheral neuropathy (DPN) and its risk factors in the type 2 diabetes mellitus (T2DM) population. Methods This cross‐sectional study enroled patients with T2DM between July and December 2017 from 24 provinces in China. Diabetic peripheral neuropathy and its severity were assessed by the Toronto clinical scoring system, neuropathy symptoms score (NSS) and neuropathy disability score. The prevalence of DPN and its risk factors were analysed. Results A total of 14,908 patients with T2DM were enroled. The prevalence of DPN was 67.6%. Among 10,084 patients with DPN, 4808 (47.7%), 3325 (33.0%), and 1951 (19.3%) had mild, moderate, and severe DPN, respectively. The prevalence of DPN in females was higher than in males (69.0% vs. 66.6%, P  = 0.002). The prevalence of DPN increased with age and course of diabetes and decreased with body mass index (BMI) and education level (all P for trend 〈 0.05). The comorbidities and complications in patients with DPN were higher than in those without DPN, including hypertension, myocardial infarction, diabetic retinopathy, and diabetic nephropathy (all P   〈  0.001). Age, hypertension, duration of diabetes, diabetic retinopathy, diabetic nephropathy, glycated haemoglobin, high‐density lipoprotein cholesterol, and lower estimated glomerular filtration rate were positively associated with DPN, while BMI, education level, fasting C‐peptide, and uric acid were negatively associated with DPN. Conclusions Among patients with T2DM in China, the prevalence of DPN is high, especially in the elderly, low‐income, and undereducated patients.
    Type of Medium: Online Resource
    ISSN: 1520-7552 , 1520-7560
    Language: English
    Publisher: Wiley
    Publication Date: 2023
    detail.hit.zdb_id: 2001565-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Journal of Diabetes, Wiley, Vol. 9, No. 5 ( 2017-05), p. 495-501
    Abstract: 背景 既往研究显示,在中国接受胰岛素治疗的2型糖尿病患者使用自我血糖监测的情况并不理想。本研究旨在评价结构化自我血糖监测策略对改善血糖控制和提高自我血糖监测频率的有效性。 方法 年龄≥ 18岁、接受胰岛素治疗 〉 3个月、HbA 1c 〉 8%(64 mmol/mol)的2型糖尿病患者入选本研究。本研究为糖尿病患者提供自我血糖监测所需的材料,指导患者按照胰岛素治疗方案进行结构化的自我血糖监测。研究者培训患者根据自我血糖监测结果自行调整胰岛素剂量,并在研究3个月和6个月时进行中心访视。研究终点包括糖化血红蛋白的变化、自我血糖监测频率的变化以及低血糖发生频率的改变。 结果 本研究从中国19个中心入选了820例接受胰岛素治疗的2型糖尿病患者。患者的平均年龄为55.1 ± 9.8岁,体重指数为24.9 ± 3.6 kg/m 2 ,糖化血红蛋白为9.7 ± 1.6%(83 mmol/mol),糖尿病病程为9.8 ± 7.1年,胰岛素治疗时间的中位数为30.3(3.0‐274.1)月。在研究3个月时,99.9%的患者能够每日进行自我血糖监测。在研究3个月和6个月时,患者的糖化血红蛋白较基线分别下降1.81%和1.73%( P 均 〈 0.0001),同时低血糖发生频率降低。此外,研究3个月和6个月时糖化血红蛋白控制达标 〈 7.0%(53 mmol/mol)的患者比例分别为36.2%和39.9%。其中糖尿病病程和胰岛素治疗时间较短的患者糖化血红蛋白改善的幅度最大。 结论 结构化自我血糖监测策略培训患者解读自我血糖监测数据,并根据监测结果进行相应调整。对于接受胰岛素治疗的2型糖尿病患者,该策略在增加自我血糖监测频率的同时可改善患者的血糖控制。
    Type of Medium: Online Resource
    ISSN: 1753-0393 , 1753-0407
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2017
    detail.hit.zdb_id: 2485432-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...